Unichem Labs gets tentative nod for ANDA of sitagliptin tablets

Unichem Laboratories announced that it has received tentative approval for ANDA of Sitagliptin Tablets USP, 25 mg, 50 mg, and 100 mg from the United States Food and Drug Administration (USFDA).
The product is generic version of Januvia (sitagliptin) tablets, 25 mg, 50 mg, and 100 mg, of Merck Sharpe and Dohme Corp (Merck).
Sitagliptin tablets are indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. Product will be commercialized from Unichem's Goa Plant on receipt of full approval.
The announcement was made on Saturday, 10 July 2021. Shares of Unichem Laboratories fell 0.2% to settle at Rs 327.80 on Friday, 9 July 2021.

Related Keywords

United States ,Merck Sharpe ,Drug Administration ,Dohme Corp Merck ,Unichem Laboratories ,Sitagliptin Tablets ,United States Food ,Dohme Corp ,Goa Plant ,Capital Market ,ஒன்றுபட்டது மாநிலங்களில் ,மெர்க் கூர்மையான ,ஒன்றுபட்டது மாநிலங்களில் உணவு ,கோவா ஆலை ,மூலதனம் சந்தை ,